These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 23958057)

  • 1. High plasma fibrinogen concentration and platelet count unfavorably impact survival in non-small cell lung cancer patients with brain metastases.
    Zhu JF; Cai L; Zhang XW; Wen YS; Su XD; Rong TH; Zhang LJ
    Chin J Cancer; 2014 Feb; 33(2):96-104. PubMed ID: 23958057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Analysis of the factors associated with abnormal coagulation and prognosis
 in patients with non-small cell lung cancer].
    Li Y; Wei S; Wang J; Hong L; Cui L; Wang C
    Zhongguo Fei Ai Za Zhi; 2014 Nov; 17(11):789-96. PubMed ID: 25404269
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platelet indices in non-small cell lung cancer patients with brain metastases.
    Li MM; Wang X; Yun ZY; Wang RT; Yu KJ
    Cancer Biomark; 2019; 24(4):515-519. PubMed ID: 30932885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Can we define any marker associated with brain failure in patients with locally advanced non-small cell lung cancer?
    Sert F; Cosgun G; Yalman D; Ozkok S
    Cancer Radiother; 2021 Jun; 25(4):316-322. PubMed ID: 33422415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of increased mean platelet volume (MPV) and decreased MPV/platelet count ratio as poor prognostic factors in lung cancer.
    Omar M; Tanriverdi O; Cokmert S; Oktay E; Yersal O; Pilancı KN; Menekse S; Kocar M; Sen CA; Ordu C; Goksel G; Meydan N; Barutca S;
    Clin Respir J; 2018 Mar; 12(3):922-929. PubMed ID: 28026133
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preoperative platelet count in predicting lymph node metastasis and prognosis in patients with non-small cell lung cancer.
    Liu HB; Gu XL; Ma XQ; Lv TF; Wu Y; Xiao YY; Yuan DM; Li YF; Song Y
    Neoplasma; 2013; 60(2):203-8. PubMed ID: 23259790
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Elevated serum C-reactive protein, carcinoembryonic antigen and N2 disease are poor prognostic indicators in non-small cell lung cancer.
    Ni XF; Wu P; Wu CP; Ji M; Wu J; Gu XF; Jiang ZX
    Asia Pac J Clin Oncol; 2015 Dec; 11(4):e22-30. PubMed ID: 24889374
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor response and survival in patients with advanced non-small-cell lung cancer: the predictive value of chemotherapy-induced changes in fibrinogen.
    Zhao J; Zhao M; Jin B; Yu P; Hu X; Teng Y; Zhang J; Luo Y; Zhang L; Zheng S; Zhou Q; Li H; Liu Y; Qu X
    BMC Cancer; 2012 Aug; 12():330. PubMed ID: 22852778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for brain metastases from non-small-cell lung cancer: A protocol for observational study.
    He J; Wang X; Xiao R; Zuo W; Zhang W; Yao H
    Medicine (Baltimore); 2021 Mar; 100(9):e24724. PubMed ID: 33655937
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic role of preoperative platelet, fibrinogen, and D-dimer levels in patients with non-small cell lung cancer: A multicenter prospective study.
    Hou C; Jiang F; Ma H; Zhu Q; Wang Z; Zhao B; Xue T; Tan S; Yang R; Qian Y; Luo X; Zhao M; Xu X; Chen L; Li J
    Thorac Cancer; 2019 Feb; 10(2):304-311. PubMed ID: 30609303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of initial platelet counts and fibrinogen level in advanced non-small cell lung cancer.
    Kim KH; Park TY; Lee JY; Lee SM; Yim JJ; Yoo CG; Kim YW; Han SK; Yang SC
    J Korean Med Sci; 2014 Apr; 29(4):507-11. PubMed ID: 24753697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Research on the coagulation function changes in non small cell lung cancer patients and analysis of their correlation with metastasis and survival.
    Qi Y; Fu J
    J BUON; 2017; 22(2):462-467. PubMed ID: 28534370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relation between tumor FDG uptake and hematologic prognostic indicators in stage I lung cancer patients following curative resection.
    Jeong E; Hyun SH; Moon SH; Cho YS; Kim BT; Lee KH
    Medicine (Baltimore); 2017 Feb; 96(5):e5935. PubMed ID: 28151879
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peripheral Blood Lymphocytes and Platelets Are Prognostic in Surgical pT1 Non-Small Cell Lung Cancer.
    Sulibhavi A; Asokan S; Miller MI; Moreira P; Daly BD; Fernando HC; Litle VR; Suzuki K
    Ann Thorac Surg; 2020 Feb; 109(2):337-342. PubMed ID: 31593659
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The combination of plasma fibrinogen and neutrophil lymphocyte ratio (F-NLR) is a predictive factor in patients with resectable non small cell lung cancer.
    Wang H; Zhao J; Zhang M; Han L; Wang M; Xingde L
    J Cell Physiol; 2018 May; 233(5):4216-4224. PubMed ID: 29057536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of CD37, cystatin A, and IL-23A gene expression in association with brain metastasis: analysis of a prospective trial.
    Dohm A; Su J; McTyre ER; Taylor JM; Miller LD; Petty WJ; Xing F; Lo HW; Metheny-Barlow LJ; O'Neill S; Bellinger C; Dotson T; Pasche B; Watabe K; Chan MD; Ruiz J
    Int J Biol Markers; 2019 Mar; 34(1):90-97. PubMed ID: 30854931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AXL-GAS6 expression can predict for adverse prognosis in non-small cell lung cancer with brain metastases.
    Wu X; Ma W; Zhou Q; Yan H; Lim ZF; Huang M; Deng C; Yu X; Su H; Komo S; Yang H; Zhang X; Wen S; Zhang Z; Ma PC
    J Cancer Res Clin Oncol; 2017 Oct; 143(10):1947-1957. PubMed ID: 28551766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum Biomarkers Associated with Clinical Outcomes Fail to Predict Brain Metastases in Patients with Stage IV Non-Small Cell Lung Cancers.
    Li BT; Lou E; Hsu M; Yu HA; Naidoo J; Zauderer MG; Sima C; Johnson ML; Daras M; DeAngelis LM; Fleisher M; Kris MG; Azzoli CG
    PLoS One; 2016; 11(1):e0146063. PubMed ID: 26730601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of lymphocyte-to-monocyte ratio and systemic immune-inflammation index in non-small-cell lung cancer patients with brain metastases.
    Li A; Mu X; He K; Wang P; Wang D; Liu C; Yu J
    Future Oncol; 2020 Oct; 16(30):2433-2444. PubMed ID: 32664750
    [No Abstract]   [Full Text] [Related]  

  • 20. Neutrophil-to-Lymphocyte ratio (NLR) and Platelet-to-Lymphocyte ratio (PLR) as prognostic markers in patients with non-small cell lung cancer (NSCLC) treated with nivolumab.
    Diem S; Schmid S; Krapf M; Flatz L; Born D; Jochum W; Templeton AJ; Früh M
    Lung Cancer; 2017 Sep; 111():176-181. PubMed ID: 28838390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.